Fumaric Acid

Fumaric Acid

SCHEMBL7482995

COc1ccccc1C(=O)Nc1ccc2[nH]cc(C3CCN(C)CC3)c2c1.O=C(O)/C=C/C(=O)O

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
HTR1B P28222 12/20 0.61
HTR1A P08908 3/20 0.61
HTR1F P30939 3/20 0.61
HTR1D P28221 12/20 0.61
MAPT P10636 1/20 0.59
BLM P54132 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
HTR6 P50406 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL7483000 1.00 HTR1B (0.61) HTR1BHTR1AHTR1FHTR1DMAPT
Fumaric Acid SCHEMBL7484611 0.88 HTR1D (0.65) HTR1BHTR1AHTR1FHTR1DMAPT
Fumaric Acid SCHEMBL7484604 0.88 HTR1D (0.65) HTR1BHTR1AHTR1FHTR1DMAPT
SCHEMBL7483580 0.87 HTR1B (0.64) HTR1BHTR1AHTR1FHTR1D
Fumaric Acid SCHEMBL7488518 0.84 HTR1D (0.71) HTR1BHTR1AHTR1FHTR1DMAPT
Fumaric Acid SCHEMBL7488528 0.84 HTR1D (0.71) HTR1BHTR1AHTR1FHTR1DMAPT
Fumaric Acid SCHEMBL7484476 0.84 HTR1A (0.63) HTR1BHTR1AHTR1FHTR1DMAPT
Fumaric Acid SCHEMBL7484479 0.84 HTR1A (0.63) HTR1BHTR1AHTR1FHTR1DMAPT
SCHEMBL7489360 0.83 HTR1D (0.74) HTR1BHTR1AHTR1FHTR1D
SCHEMBL7483870 0.83 HTR1D (0.70) HTR1BHTR1AHTR1FHTR1DHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0733628-B9 5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1H-indoles: 5-HT1F agonists LILLY CO ELI (US) 2002-06-12 EP disclosed
US-6380201-B1 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists ELI LILLY AND COMPANY 2002-04-30 US disclosed
EP-0733628-B1 5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1H-indoles: 5-HT1F agonists LILLY CO ELI (US) 2000-12-27 EP disclosed
US-5962473-A Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F ELI LILLY AND COMPANY (US) 1999-10-05 US disclosed
US-5962474-A ANALGESICS; HEADACHES ELI LILLY AND COMPANY (US) 1999-10-05 US disclosed
EP-0832650-A2 Use of serotonin 5-HT1F agonists for the prevention of migraine ELI LILLY AND COMPANY (US) 1998-04-01 EP disclosed
EP-0824917-A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis ELI LILLY AND COMPANY (US) 1998-02-25 EP disclosed
US-5708008-A TREATMENT OF MIGRAINE ELI LILLY AND COMPANY (US) 1998-01-13 US disclosed
WO-1996029075-A1 5-SUBSTITUTED-3-(1,2,3,6-TETRAHYDROPYRIDIN-4-YL)- AND 3-(PIPERIDIN-4-YL)-1H-INDOLES: NEW 5-HT1F AGONISTS ELI LILLY AND COMPANY (US) 1996-09-26 WO disclosed
EP-0733628-A1 5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists ELI LILLY AND COMPANY (US) 1996-09-25 EP disclosed